EDAP TMS S.A. (EDAP) – FDA
-
EDAP (EDAP) Announces FDA Breakthrough Device Designation for Focal OneĀ® in the Treatment of Deep Infiltrating Rectal Endometriosis
-
EDAP TMS S.A. (EDAP) Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to EDAP Stock Lookup